Iopromide
Radiographic Contrast Agent — VARIOUS
Also known as: iopromidum
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Iopromide is an ofp drug in the Radiographic Contrast Agent class catalogued in DrugCentral. It was first approved by the FDA in 1995. Its mechanism of action is classified as X-Ray Contrast Activity.
- Approval status: ofp (first approved 1995 by the FDA).
- Drug class: Radiographic Contrast Agent.
- Mechanism of action: X-Ray Contrast Activity.
- ATC code: V08AB05 (Watersoluble, nephrotropic, low osmolar X-ray contrast media).
- Molecular formula: C18H24I3N3O8; molecular weight 791.12 g/mol.
Mechanism & targets
| Mechanism of action (MoA) | X-Ray Contrast Activity |
|---|---|
| Established pharmacologic class | Radiographic Contrast Agent |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1995-05-10 | FDA | — | BAYER HLTHCARE |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
V08AB05 | VARIOUS › CONTRAST MEDIA › X-RAY CONTRAST MEDIA, IODINATED › Watersoluble, nephrotropic, low osmolar X-ray contrast media |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Anaphylactic shock | 1111.7 |
| Contrast media allergy | 978.8 |
| Blood pressure decreased | 795.2 |
| Urticaria | 656.0 |
| Erythema | 538.7 |
| Contrast media reaction | 512.2 |
| Contrast encephalopathy | 465.3 |
| Pruritus | 383.8 |
| Respiratory rate increased | 368.9 |
| Nephropathy toxic | 356.1 |
| Blood pressure immeasurable | 328.3 |
| Sneezing | 321.8 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Iopromide is on its molecule page.
| Molecular formula | C18H24I3N3O8 |
|---|---|
| Molecular weight | 791.12 g/mol |
| CAS number | 73334-07-3 |
| InChIKey | DGAIEPBNLOQYER-UHFFFAOYSA-N |
| PubChem CID | 3736 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Iopromide work?
Iopromide is classified as X-Ray Contrast Activity.
When was Iopromide first approved?
Iopromide was first approved by the FDA in 1995.
What drug class does Iopromide belong to?
Iopromide is in the Radiographic Contrast Agent class.
What is the chemical formula of Iopromide?
Iopromide has the molecular formula C18H24I3N3O8 and a molecular weight of 791.12 g/mol.
Browse: all drugs starting with I · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1468 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1725 — compound record and bioactivity
- PubChem CID 3736 — chemical identifiers
- DrugBank DB09156 — drug record
- FDA UNII 712BAC33MZ — substance identity
- DailyMed: FDA labels for Iopromide — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.